Goldman Sachs poised to buy into ice cream maker Froneri at $17.13 billion valuation, FT says

Goldman Sachs poised to buy into ice cream maker Froneri at $17.13 billion valuation, FT says

(Reuters) -Goldman Sachs is poised to buy into ice cream maker Froneri at a 15-billion-euro ($17.13 billion) valuation including debt, the Financial Times reported on Friday. Reuters could not immediately verify the report. The deal, which could be signed as soon as September, would involve Goldman’s asset management division becoming the lead investor in a…

Read More
CSX talks with investment bank about merger options

CSX talks with investment bank about merger options

CSX has declined to comment on a Bloomberg report that it has engaged Goldman Sachs to advise it about potential merger options. Today’s news follows this week’s announcement that Union Pacific (NYSE: UNP) will acquire Norfolk Southern (NYSE: NSC) in an $85 billion deal that would create the first transcontinental freight railroad. Industry analysts believe…

Read More
Wuxi AppTec raises US$981 mn in Hong Kong offer amid growing appetite for Chinese biotech

Wuxi AppTec raises US$981 mn in Hong Kong offer amid growing appetite for Chinese biotech

Wuxi AppTec, Asia’s largest provider of contract pharmaceutical research, has raised HK$7.70 billion (US$981 million) through a sale of additional shares in Hong Kong as it rides the wave of bullish appetite for Chinese biotechnology shares. The Shanghai-based company sold 73.8 million new shares to institutional investors at HK$104.27 each, a 6.9 per cent discount…

Read More
Wuxi AppTec raises US$981 mn in Hong Kong offer amid growing appetite for Chinese biotech

Wuxi AppTec raises US$981 mn in Hong Kong offer amid growing appetite for Chinese biotech

Wuxi AppTec, Asia’s largest provider of contract pharmaceutical research, has raised HK$7.70 billion (US$981 million) through a sale of additional shares in Hong Kong as it rides the wave of bullish appetite for Chinese biotechnology shares. The Shanghai-based company sold 73.8 million new shares to institutional investors at HK$104.27 each, a 6.9 per cent discount…

Read More